Vijaya Sai Reddy resigned from the YSR Congress Party (YSRCP) as he had ‘lost his trust’ in the party president Y. S. Jagan Mohan Reddy. Addressing the media after participating in a ‘Thali ...

“Can the Union Minister who ridiculed Telangana CM do the same with the Maharashtra Chief Minister who also signed MoUs with the same companies at Davos,” he asked and advised Mr. Kishan Reddy ...

Vijayasai Reddy, who is known to be close aide of YSR Congress Party chief Jagan Reddy has decided to quit politics and resign from Rajya Sabha on Saturday. Vijayasai Reddy is the National ...

Stock Market today: Dr Reddy's Laboratories share price declined more than 6% in the morning trades on Friday post Q3 results that were announced after the market hours of Thursday ...

YSRCP Rajya Sabha member V Vijayasai Reddy on Friday said he will be resigning from his parliament membership on January 25. In a post on 'X', he said he is not joining any other party and also ...

Rajya Sabha MP V Vijayasai Reddy on Friday announced his retirement from politics, saying that going forward, he will focus on agriculture. He added that the decision to retire was ‘entirely ...

(Image: Freepik) Dr Reddy’s Lab share prices fell 5.5% to a low of Rs 1,218 as soon as the scrip started trading on the National Stock Exchanges on January 24. The dip in the share price of Dr ...

Senior YSR Congress Party leader V. Vijaysai Reddy has announced his retirement from politics and his resignation from the Rajya Sabha, emphasizing that the decision is personal and not influenced ...

Amravati (Andhra Pradesh) [India], January 24 (ANI): YSRCP Member of Parliament Vijaysai Reddy has announced his retirement from politics, stating that he will resign from his Rajya Sabha ...

Dr. Reddy's shares in Friday's trade saw a sharp fall following the company's weak set of earnings for the December quarter. It highlighted that weakness in core profitability shows up. Also, it ...

Dr Reddy's: The pharma company reported a consolidated net profit increased 2 per cent to ₹1,413 crore in the third quarter ended December 31, 2024, driven by robust performance across markets.